当前位置： SCI文献检索 > PEDIATRIC BLOOD & CANCER期刊下所有文献 > Gastrostomy Complications in Pediatric Cancer Patients: A Retrospective Single-Institution Review.

Gastrostomy Complications in Pediatric Cancer Patients: A Retrospective Single-Institution Review.

Abstract：

BACKGROUND:Complications in pediatric cancer patients after a gastrostomy (GT) placement have not been widely investigated. We aimed to evaluate the complication rate and nature of complications in this specific population. PROCEDURE:Medical records of pediatric cancer patients having a GT placed at our institution from 1998 to 2013 were retrospectively reviewed. Variables analyzed included gender, age, diagnosis, surgical procedure, GT device, duration of GT usage, absolute neutrophil count (ANC) level at surgery, and complications. RESULTS:One hundred seventy-one patients (92 males, 79 females), median age of 6 years (range, 0.2-21), who underwent 181 procedures (110 open, 59 endoscopic, and 12 laparoscopic) were identified. Diagnosis included central nervous system tumor (n = 101), solid tumor (n = 45), and leukemia/lymphoma (n = 25). A GT tube was used in 139 procedures and a GT button in 42. Median ANC level at procedure was 3,300/mm(3) (range, 0-38,988). Median duration of GT usage was 8 months (range, 0.2-142). One hundred seventy-seven complications occurred in 106 patients (61.9%) and were categorized as perioperative (<1 month after surgery, 20.3%) and late (>1 month after surgery, 79.7%). Major complications included 42 (23.7%) GT site infections and four (2.2%) intrabdominal complications. The most common minor complication was granulation tissue (28.8%). Younger age at procedure was associated with complications (P = 0.048) and an open technique was associated with GT site infection (P = 0.003). No statistical significance was observed between complications and gender, diagnosis, GT device, duration of GT usage, and ANC at procedure. CONCLUSIONS:Younger patients were more likely to have complications, and GT site infections were more common after open GT procedures.

journal_name

Pediatr Blood Cancer

journal_title

Pediatric blood & cancer

authors

Fernandez-Pineda I,Sandoval JA,Jones RM,Boateng N,Wu J,Rao BN,Davidoff AM,Shochat SJ

doi

10.1002/pbc.25968

subject

Has Abstract

pub_date

2016-07-01 00:00:00

pages

1250-3

issue

7

eissn

1545-5009

issn

1545-5017

journal_volume

63

pub_type

杂志文章

相关文献

PEDIATRIC BLOOD & CANCER文献大全
  • Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.

    abstract：BACKGROUND:Hepatoblastoma is a rare malignancy of childhood. The scarcity of adequate cell models has limited our understanding of this tumor. Here we describe and characterize a new human liver tumor cell line, Hep293TT, derived from an aggressive childhood hepatoblastoma. PROCEDURES:Hep293TT cells were established u...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22187

    authors： Chen TT,Rakheja D,Hung JY,Hornsby PJ,Tabaczewski P,Malogolowkin M,Feusner J,Miskevich F,Schultz R,Tomlinson GE

    更新日期：2009-12-01 00:00:00

  • The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial.

    abstract：:Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.26013

    authors： Nimmer M,Czachor J,Turner L,Thomas B,Woodford AL,Carpenter K,Gonzalez V,Liem RI,Ellison A,Casper TC,Brousseau DC,sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN).

    更新日期：2016-09-01 00:00:00

  • Spiritual assessment and spiritual care offerings as a standard of care in pediatric oncology: A recommendation informed by a systematic review of the literature.

    abstract：:Children with cancer and their families experience shifts in spiritual wellness from diagnosis through treatment and survivorship or bereavement. An interdisciplinary team conducted a systematic review of quantitative and qualitative research on spiritual assessments, interventions, and outcomes in childhood cancer fo...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.27764

    authors： Robert R,Stavinoha P,Jones BL,Robinson J,Larson K,Hicklen R,Smith B,Perko K,Koch K,Findley S,Weaver MS

    更新日期：2019-09-01 00:00:00

  • Modifying bone mineral density, physical function, and quality of life in children with acute lymphoblastic leukemia.

    abstract：BACKGROUND:The early effects of childhood acute lymphoblastic leukemia (ALL) include decreased physical function, bone mineral density (BMD/g/cm2 ), and health-related quality of life (HRQL). We assessed the capacity of a physical therapy and motivation-based intervention, beginning after diagnosis and continuing throu...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1002/pbc.26929

    authors： Cox CL,Zhu L,Kaste SC,Srivastava K,Barnes L,Nathan PC,Wells RJ,Ness KK

    更新日期：2018-04-01 00:00:00

  • Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients.

    abstract：BACKGROUND:Little is known about the effects of chemotherapy on patient antibody titers to vaccine-preventable infectious diseases; thus, there is no standard protocol for revaccinating post-chemotherapy patients. PROCEDURES:To assess losses of detectable antibody titers due to chemotherapy, we retrospectively examine...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21277

    authors： Yu J,Chou AJ,Lennox A,Kleiman P,Wexler LH,Meyers PA,Gorlick R

    更新日期：2007-10-15 00:00:00

  • No improvement in clinical trial enrollment for adolescents and young adults with cancer at a children's hospital.

    abstract：BACKGROUND:We have previously published data from 2001 to 2006 showing that adolescent and young adult (AYA) oncology patients have significantly lower therapeutic clinical trial enrollment rates than younger patients. Our objective was to determine if the enrollment of AYA patients on therapeutic studies at the same i...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26638

    authors： Jacob SA,Shaw PH

    更新日期：2017-12-01 00:00:00

  • Lack of mortality in 22 children with sickle cell anemia and severe malarial anemia.

    abstract：:Retrospective studies suggest that there is high mortality in children with sickle cell anemia (SCA) and severe malaria. We assessed mortality in Ugandan children with severe malarial anemia (SMA, n = 232) or cerebral malaria (CM, n = 267) by sickle cell hemoglobin genotype. Admission and 2-year follow-up mortality di...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26745

    authors： Opoka RO,Bangirana P,Idro R,Shabani E,Namazzi R,John CC

    更新日期：2018-01-01 00:00:00

  • Breast Cancer and Non-Hodgkin Lymphoma in a Young Male with Cowden Syndrome.

    abstract：:Male breast cancer (MBC) is unusual, especially in young adults. Most cases of MBC as a secondary malignancy relate to the previous treatment with ionizing radiation. MBC can be associated with mutations in hereditary cancer predisposition syndrome genes (i.e., BRCA2); however, no such association has been reported in...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25796

    authors： Hagelstrom RT,Ford J,Reiser GM,Nelson M,Pickering DL,Althof PA,Sanger WG,Coccia PF

    更新日期：2016-03-01 00:00:00

  • A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.

    abstract：BACKGROUND:The Wnt/β-catenin pathway plays a central role in the pathogenesis of most hepatoblastomas (HBs), that is, up to 60-80% carry activating CTNNB1 mutations. HBs can however also be the first manifestation of familial adenomatous polyposis (FAP). As this is a severe disease, it is important for the patient and ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26991

    authors： Dubbink HJ,Hollink IHIM,Avenca Valente C,Wang W,Liu P,Doukas M,van Noesel MM,Dinjens WNM,Wagner A,Smits R

    更新日期：2018-06-01 00:00:00

  • Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?

    abstract：BACKGROUND:Fever in severe chemotherapy-induced neutropenia (FN) is the most frequent manifestation of a potentially lethal complication of current intensive chemotherapy regimens. This study aimed at establishing models predicting the risk of FN, and of FN with bacteremia, in pediatric cancer patients. METHODS:In a s...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21726

    authors： Wicki S,Keisker A,Aebi C,Leibundgut K,Hirt A,Ammann RA

    更新日期：2008-12-01 00:00:00

  • Long-term cause-specific mortality among five-year survivors of childhood cancer.

    abstract：BACKGROUND:The purpose of our study was to assess long-term cause-specific mortality of 5-year childhood cancer survivors. PROCEDURE:The study population consisted of 1,378 patients who had been treated for childhood cancer in The Netherlands between 1966 and 1996 and survived at least 5 years; follow-up was complete ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20028

    authors： Cardous-Ubbink MC,Heinen RC,Langeveld NE,Bakker PJ,Voûte PA,Caron HN,van Leeuwen FE

    更新日期：2004-06-01 00:00:00

  • High dose alkylator therapy for extracranial malignant rhabdoid tumors in children.

    abstract：BACKGROUND:Extracranial malignant rhabdoid tumor (MRT) is a rare pediatric cancer with a poor prognosis. The kidney is the most common site. Isolated reports have shown improvements in patient survival, but no specific treatment regimen has shown efficacy over others. PROCEDURE:Retrospective review of patients diagnos...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.25093

    authors： Venkatramani R,Shoureshi P,Malvar J,Zhou S,Mascarenhas L

    更新日期：2014-08-01 00:00:00

  • Renal cell carcinoma harboring somatic TSC2 mutations in a child with methylmalonic acidemia.

    abstract：:Pediatric renal cell carcinoma (RCC) is a rare cancer that can be associated with inherited diseases including tuberous sclerosis complex (TSC) caused by germline mutations in TSC1 or TSC2. Somatic mutations in TSC1 and TSC2 have also been reported in adult RCC, which predict response to mTOR inhibitors. Here, we pres...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26286

    authors： Potter SL,Venkatramani R,Wenderfer S,Graham BH,Vasudevan SA,Sher A,Wu H,Wheeler DA,Yang Y,Eng CM,Gibbs RA,Roy A,Plon SE,Parsons DW

    更新日期：2017-05-01 00:00:00

  • The role of myeloablative chemotherapy with autologous hematopoietic cell rescue in central nervous system germ cell tumors.

    abstract：:This review of the experience of high dose chemotherapy in patients with recurrent or refractory intracranial germ cell tumor confirms that sustained tumor control can be achieved with this modality both in germinoma and non-germinomatous germ cell tumors. Data from cooperative groups in Europe and North America sugge...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.22376

    authors： Bouffet E

    更新日期：2010-04-01 00:00:00

  • Weight and height in children newly diagnosed with cancer.

    abstract：BACKGROUND:Although weight loss and lack of linear growth occur in children with cancer, growth history is not included in research that aims to determine nutritional status in children newly diagnosed with cancer. Therefore, this study aimed to determine weight loss and lack of linear growth in this patient group. PR...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.25301

    authors： Brinksma A,Roodbol PF,Sulkers E,Hooimeijer HL,Sauer PJ,van Sonderen E,de Bont ES,Tissing WJ

    更新日期：2015-02-01 00:00:00

  • Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse.

    abstract：BACKGROUND:Tumor cells frequently contaminate autologous stem cell products in a variety of malignancies, but their clinical significance remains controversial. We retrospectively monitored tumor contamination in stem cell harvests from patients with Ewing family of tumors (EFT) all harboring the specific translocation...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20022

    authors： Yaniv I,Cohen IJ,Stein J,Zilberstein J,Liberzon E,Atlas O,Grunshpan A,Sverdlov Y,Ash S,Zaizov R,Avigad S

    更新日期：2004-05-01 00:00:00

  • Access to specialized pediatric cancer care in Switzerland.

    abstract：BACKGROUND:Specialized pediatric cancer centers (PCCs) are thought to be essential to obtain state-of-the-art care for children and adolescents. We determined the proportion of childhood cancer patients not treated in a PCC, and described their characteristics and place of treatment. PROCEDURE:The Swiss Childhood Canc...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,多中心研究

    doi：10.1002/pbc.22426

    authors： Adam M,von der Weid N,Michel G,Zwahlen M,Lutz JM,Probst-Hensch N,Niggli F,Kuehni C,Swiss Pediatric Oncology Group (SPOG).,Swiss Association of Cancer Registries (ASRT).

    更新日期：2010-05-01 00:00:00

  • The importance of enteral nutrition to prevent or treat undernutrition in children undergoing treatment for cancer.

    abstract：:Nutrition therapy is a therapeutic approach to treating medical conditions and symptoms via diet, which can be done by oral, enteral or parenteral routes. It is desirable to include nutritional interventions as a standard of care in pediatric cancer units (PCUs) at all levels of care. The interventions are dependent o...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.28378

    authors： Trehan A,Viani K,da Cruz LB,Sagastizado SZ,Ladas EJ

    更新日期：2020-06-01 00:00:00

  • Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.

    abstract：BACKGROUND:Patients with sickle cell disease (SCD) receiving chronic blood transfusions are at risk of developing iron overload and organ toxicity. Chelation therapy with either subcutaneous (SQ) desferrioxamine (DFO) or oral deferasirox is effective in preventing and reducing iron overload but poses significant challe...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22660

    authors： Kalpatthi R,Peters B,Kane I,Holloman D,Rackoff E,Disco D,Jackson S,Laver JH,Abboud MR

    更新日期：2010-12-15 00:00:00

  • A single-center experience with undifferentiated embryonal sarcoma of the liver.

    abstract：:Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26154

    authors： Mathias MD,Ambati SR,Chou AJ,Slotkin EK,Wexler LH,Meyers PA,Magnan H

    更新日期：2016-12-01 00:00:00

  • A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.

    abstract：BACKGROUND:To evaluate efficacy, pharmacokinetics (PK) and pharmacodynamics of single-agent everolimus in pediatric patients with radiographically progressive low-grade glioma (LGG). METHODS:Everolimus was administered at 5 mg/m2 once daily as a tablet or liquid for a planned 48-week duration or until unacceptable tox...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28787

    authors： Wright KD,Yao X,London WB,Kao PC,Gore L,Hunger S,Geyer R,Cohen KJ,Allen JC,Katzenstein HM,Smith A,Boklan J,Nazemi K,Trippett T,Karajannis M,Herzog C,Destefano J,Direnzo J,Pietrantonio J,Greenspan L,Cassidy D,Sch

    更新日期：2021-02-01 00:00:00

  • Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.

    abstract：BACKGROUND:Thiotepa and carboplatin are known to be active in central nervous system tumors. Topotecan potentiates the anti-cancer effects of alkylators and crosses the blood-brain barrier. We present ten patients with recurrent or progressive central nervous system malignancies treated on a myeloablative regimen using...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.22347

    authors： Gilheeney SW,Khakoo Y,Souweidane M,Wolden S,Boulad F,Dunkel IJ

    更新日期：2010-04-01 00:00:00

  • Caregiver and health care provider preferences of nutritional support in a hematopoietic stem cell transplant unit.

    abstract：BACKGROUND:Many pediatric oncology patients undergoing hematopoietic stem cell transplantation (HSCT) require nutritional support (NS) because of their inability to consume adequate caloric intake enough calories orally. Although NS can be provided either enteraly (EN) or parenteraly (PN), EN is the preferred method of...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25473

    authors： Williams-Hooker R,Adams M,Havrilla DA,Leung W,Roach RR,Mosby TT

    更新日期：2015-08-01 00:00:00

  • Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.

    abstract：:We present three pediatric patients with BRAFV600E mutant high-grade gliomas treated by vemurafenib on a nominative authorization level at our institution. One patient with anaplastic ganglioglioma experienced confirmed partial tumor response and significant clinical improvement and she is alive 20 months after start ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24891

    authors： Bautista F,Paci A,Minard-Colin V,Dufour C,Grill J,Lacroix L,Varlet P,Valteau-Couanet D,Geoerger B

    更新日期：2014-06-01 00:00:00

  • Parents' responses to prognostic disclosure at diagnosis of a child with a high-risk brain tumor: Analysis of clinician-parent interactions and implications for clinical practice.

    abstract：BACKGROUND:Previous studies have found that parents of children with cancer desire more prognostic information than is often given even when prognosis is poor. We explored in audio-recorded consultations the kinds of information they seek. METHODS:Ethnographic study including observation and audio recording of consult...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28802

    authors： Bluebond-Langner M,Hall N,Vincent K,Henderson EM,Russell J,Beecham E,Bryan G,Gains JE,Gaze MN,Slater O,Langner RW,Hargrave D

    更新日期：2021-03-01 00:00:00

  • Hydroxyurea treatment of children with hemoglobin SC disease.

    abstract：:The efficacy of hydroxyurea in hemoglobin SC (HbSC) patients is not well documented. We describe the long-term response to hydroxyurea in children with clinically severe HbSC. In 15 patients, hydroxyurea resulted in a significant increase in mean corpuscular volume (MCV) and fetal hemoglobin (HbF) and a significant de...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24283

    authors： Yates AM,Dedeken L,Smeltzer MP,Lebensburger JD,Wang WC,Robitaille N

    更新日期：2013-02-01 00:00:00

  • Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma.

    abstract：:We describe 12 pediatric patients (8-16 years) with primary refractory (N = 6) or first relapse (N = 6) Hodgkin lymphoma (HL) treated with ifosfamide, gemcitabine, and vinorelbine (IGEV). The overall response rate to IGEV was 100%, with seven (58%) complete responses (CR) and five (42%) partial responses. Successful C...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.28167

    authors： Marr K,Ronsley R,Nadel H,Douglas K,Gershony S,Strahlendorf C,Davis JH,Deyell RJ

    更新日期：2020-04-01 00:00:00

  • Female reproductive function after treatment of childhood acute lymphoblastic leukemia.

    abstract：BACKGROUND:The aim was to evaluate self-reported reproductive characteristics and markers of ovarian function in a nationwide cohort of female survivors of childhood acute lymphoblastic leukemia (ALL), because prior investigations have produced conflicting data. PROCEDURE:Self-reported reproductive characteristics wer...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28894

    authors： Roshandel R,van Dijk M,Overbeek A,Kaspers G,Lambalk C,Beerendonk C,Bresters D,van der Heiden-van der Loo M,van den Heuvel-Eibrink M,Kremer L,Loonen J,van der Pal H,Ronckers C,Tissing W,Versluys B,van Leeuwen F,van den Ber

    更新日期：2021-01-18 00:00:00

  • Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.

    abstract：:The commonly accepted definition of Fanconi anemia (FA) relying on DNA repair deficiency is submitted to a critical review starting from the early reports pointing to mitomycin C bioactivation and to the toxicity mechanisms of diepoxybutane and a group of nitrogen mustards causing DNA crosslinks in FA cells. A critica...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.25452

    authors： Pagano G,d'Ischia M,Pallardó FV

    更新日期：2015-07-01 00:00:00

  • A comparison of pediatric, adolescent, and adult testicular germ cell malignancy.

    abstract：BACKGROUND:Testicular germ cell tumors (T-GCTs) occur from infancy to adulthood, and are the most common solid tumor in adolescent and young adult males. Traditionally, pediatric T-GCTs were perceived as more indolent than adult T-GCTs. However, there are few studies comparing these groups and none that specifically ev...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24773

    authors： Cost NG,Lubahn JD,Adibi M,Romman A,Wickiser JE,Raj GV,Sagalowsky AI,Margulis V

    更新日期：2014-03-01 00:00:00